PIK3CA and aneurysmal bone cyst: In Cohort B of the randomized phase 3 IPATunity130 trial, adding ipatasertib to paclitaxel did not improve PFS in PIK3CA/AKT1/PTEN-altered HR+ HER2– aBC.